SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-245365
Filing Date
2021-08-13
Accepted
2021-08-13 07:13:08
Documents
14
Period of Report
2021-08-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d340780d8k.htm   iXBRL 8-K 27006
2 EX-99.1 d340780dex991.htm EX-99.1 133161
  Complete submission text file 0001193125-21-245365.txt   338754

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA me-20210813.xsd EX-101.SCH 4472
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE me-20210813_def.xml EX-101.DEF 13898
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE me-20210813_lab.xml EX-101.LAB 23340
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE me-20210813_pre.xml EX-101.PRE 14865
7 EXTRACTED XBRL INSTANCE DOCUMENT d340780d8k_htm.xml XML 5747
Mailing Address 223 NORTH MATHILDA AVENUE SUNNYVALE CA 94086
Business Address 223 NORTH MATHILDA AVENUE SUNNYVALE CA 94086 (650) 938-6300
23andMe Holding Co. (Filer) CIK: 0001804591 (see all company filings)

IRS No.: 871240344 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-39587 | Film No.: 211169715
SIC: 2834 Pharmaceutical Preparations